Genomics, Epidemiology, Diagnostics and Management of Human Respiratory Viruses
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Microbiology".
Deadline for manuscript submissions: closed (16 February 2024) | Viewed by 227
Special Issue Editor
Interests: air pollution; asthma/allergic rhinitis; biostatistics; data science and information visualization; environmental health; epigenetics; infectious diseases
Special Issue Information
Dear Colleagues,
Respiratory virus infections pose significant global health challenges, with viruses such as influenza, respiratory syncytial virus (RSV), human coronaviruses (including SARS-CoV-2), and others causing seasonal outbreaks and occasional pandemics. Understanding the genetic variability, transmission dynamics, and clinical outcomes of these viruses is crucial for rapidly developing and implementing effective prevention, control, and management strategies.
This Special Issue provides a unique opportunity for researchers to contribute their latest findings and advancements in the field of respiratory virus infections. It aims to explore the diverse aspects of human respiratory viruses, from genomics and epidemiology to diagnostics and management, with the ultimate goal of enhancing our understanding and strategies for combating these infections and fostering collaboration and knowledge exchange among researchers working across the globe in various disciplines related to respiratory virus infections.
Potential authors are invited to submit original research articles, reviews and perspectives that cover a wide range of topics on novel therapeutic strategies, vaccine development, antiviral therapies, and public health interventions to mitigate the impact of respiratory virus outbreaks.
Dr. Gregory P. Geba
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- genomics
- epidemiology
- diagnostics
- management
- respiratory viruses
- influenza
- RSV
- coronaviruses
- SARS-CoV-2
